chr16-1195503-C-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PP3_ModerateBS2

The NM_021098.3(CACNA1H):​c.483C>G​(p.Phe161Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000193 in 1,448,276 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Synonymous variant affecting the same amino acid position (i.e. F161F) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.000019 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

6
7
6

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: -1.04

Publications

7 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.919
BS2
High AC in GnomAdExome4 at 28 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.483C>G p.Phe161Leu missense_variant Exon 4 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.483C>G p.Phe161Leu missense_variant Exon 4 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.483C>G p.Phe161Leu missense_variant Exon 4 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.483C>G p.Phe161Leu missense_variant Exon 4 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.483C>G p.Phe161Leu missense_variant Exon 4 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.483C>G p.Phe161Leu missense_variant Exon 4 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.483C>G p.Phe161Leu missense_variant Exon 4 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.444C>G p.Phe148Leu missense_variant Exon 4 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.483C>G p.Phe161Leu missense_variant Exon 4 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.444C>G p.Phe148Leu missense_variant Exon 4 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.483C>G p.Phe161Leu missense_variant Exon 4 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.483C>G p.Phe161Leu missense_variant Exon 4 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.483C>G p.Phe161Leu missense_variant Exon 4 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.483C>G p.Phe161Leu missense_variant Exon 4 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.483C>G p.Phe161Leu missense_variant Exon 4 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.483C>G non_coding_transcript_exon_variant Exon 4 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.483C>G non_coding_transcript_exon_variant Exon 4 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.483C>G non_coding_transcript_exon_variant Exon 4 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.483C>G non_coding_transcript_exon_variant Exon 4 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.483C>G non_coding_transcript_exon_variant Exon 4 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.483C>G non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.483C>G non_coding_transcript_exon_variant Exon 4 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.483C>G non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.483C>G non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.483C>G non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.483C>G non_coding_transcript_exon_variant Exon 4 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.483C>G non_coding_transcript_exon_variant Exon 4 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.483C>G non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.483C>G non_coding_transcript_exon_variant Exon 4 of 35 ENSP00000518777.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000881
AC:
2
AN:
227114
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000196
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000193
AC:
28
AN:
1448276
Hom.:
0
Cov.:
34
AF XY:
0.0000139
AC XY:
10
AN XY:
718856
show subpopulations
African (AFR)
AF:
0.0000301
AC:
1
AN:
33266
American (AMR)
AF:
0.0000234
AC:
1
AN:
42782
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25868
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39100
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83462
European-Finnish (FIN)
AF:
0.0000191
AC:
1
AN:
52446
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5716
European-Non Finnish (NFE)
AF:
0.0000217
AC:
24
AN:
1105714
Other (OTH)
AF:
0.0000167
AC:
1
AN:
59922
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.0000166
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Sep 25, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Mar 29, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces phenylalanine with leucine at codon 161 of the CACNA1H protein (p.Phe161Leu). The phenylalanine residue is highly conserved and there is a small physicochemical difference between phenylalanine and leucine. This variant is present in population databases (rs119454947, ExAC 0.008%). This missense change has been observed in individual(s) with childhood absence epilepsy (PMID: 12891677). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CACNA1H protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Pathogenic
0.29
D
BayesDel_noAF
Pathogenic
0.20
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.77
D;.;.;.
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.13
N
LIST_S2
Uncertain
0.93
D;D;D;.
M_CAP
Pathogenic
0.46
D
MetaRNN
Pathogenic
0.92
D;D;D;D
MetaSVM
Uncertain
0.78
D
MutationAssessor
Benign
1.4
L;.;L;L
PhyloP100
-1.0
PrimateAI
Uncertain
0.78
T
PROVEAN
Pathogenic
-5.0
D;.;D;D
REVEL
Uncertain
0.64
Sift
Benign
0.087
T;.;T;T
Sift4G
Uncertain
0.014
D;.;D;D
Polyphen
0.98
D;.;D;D
Vest4
0.78
MutPred
0.87
Loss of loop (P = 0.1242);.;Loss of loop (P = 0.1242);Loss of loop (P = 0.1242);
MVP
1.0
ClinPred
0.99
D
GERP RS
-4.3
Varity_R
0.35
gMVP
0.59
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs119454947; hg19: chr16-1245503; API